{"id":343428,"date":"2025-08-22T11:53:14","date_gmt":"2025-08-22T11:53:14","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-biogen-2\/"},"modified":"2025-08-22T11:53:14","modified_gmt":"2025-08-22T11:53:14","slug":"how-to-buy-biogen-2","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biogen-2\/","title":{"rendered":"Biogen Inc. (BIIB) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Biogen Inc. (BIIB) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334081,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-343428","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Biogen Inc. (BIIB) Hisseleri Nas\u0131l Al\u0131n\u0131r - Biogen Inc. (BIIB) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Biogen Inc. (BIIB) Hisseleri Nas\u0131l Al\u0131n\u0131r - Biogen Inc. (BIIB) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Bu yenilik\u00e7i biyoteknoloji \u015firketi i\u00e7in g\u00fcncel fiyat analizi, 2025 kazan\u00e7 \u00f6ng\u00f6r\u00fcleri ve ad\u0131m ad\u0131m yat\u0131r\u0131m stratejisi ile Biogen Inc. (BIIB) hisselerine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Bu yenilik\u00e7i biyoteknoloji \u015firketi i\u00e7in g\u00fcncel fiyat analizi, 2025 kazan\u00e7 \u00f6ng\u00f6r\u00fcleri ve ad\u0131m ad\u0131m yat\u0131r\u0131m stratejisi ile Biogen Inc. (BIIB) hisselerine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin."},"intro":"T\u0131bbi yenilikle hayatlar\u0131 ger\u00e7ekten de\u011fi\u015ftiren bir \u015firkete yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Biogen Inc., d\u00fcnya \u00e7ap\u0131nda milyonlarca insan\u0131 etkileyen durumlar i\u00e7in tedaviler geli\u015ftiren n\u00f6rolojik ara\u015ft\u0131rmalar\u0131n \u00f6n saflar\u0131nda yer al\u0131yor. Son FDA onaylar\u0131 ve umut vadeden \u00fcr\u00fcn hatt\u0131yla, bu biyoteknoloji devi hem heyecan verici b\u00fcy\u00fcme potansiyeli hem de \u00f6nemli volatilite sunuyor - ila\u00e7 hisselerinin y\u00fcksek risk, y\u00fcksek getiri do\u011fas\u0131n\u0131 anlayan yat\u0131r\u0131mc\u0131lar i\u00e7in m\u00fckemmel.","intro_source":{"label":"Intro","type":"text","formatted_value":"T\u0131bbi yenilikle hayatlar\u0131 ger\u00e7ekten de\u011fi\u015ftiren bir \u015firkete yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Biogen Inc., d\u00fcnya \u00e7ap\u0131nda milyonlarca insan\u0131 etkileyen durumlar i\u00e7in tedaviler geli\u015ftiren n\u00f6rolojik ara\u015ft\u0131rmalar\u0131n \u00f6n saflar\u0131nda yer al\u0131yor. Son FDA onaylar\u0131 ve umut vadeden \u00fcr\u00fcn hatt\u0131yla, bu biyoteknoloji devi hem heyecan verici b\u00fcy\u00fcme potansiyeli hem de \u00f6nemli volatilite sunuyor - ila\u00e7 hisselerinin y\u00fcksek risk, y\u00fcksek getiri do\u011fas\u0131n\u0131 anlayan yat\u0131r\u0131mc\u0131lar i\u00e7in m\u00fckemmel."},"body_html":"<h2>\ud83d\udcc8 Biogen Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2> <p>22 A\u011fustos 2025 itibar\u0131yla, Biogen Inc. (BIIB) NASDAQ borsas\u0131nda <strong>139,12 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Takviminize not edin: <strong>29 Ekim 2025<\/strong> kesinlikle kritik - Biogen'in bir sonraki \u00e7eyrek kazan\u00e7 raporunu yay\u0131nlayaca\u011f\u0131 tarih.<\/p> <h3>BIIB i\u00e7in Kazan\u00e7 Tarihleri Neden \u00d6nemlidir?<\/h3> <p>Biyoteknoloji hisseleri klinik deneme sonu\u00e7lar\u0131 ve kazan\u00e7 raporlar\u0131na ba\u011fl\u0131 olarak y\u00fckselir veya d\u00fc\u015fer. Son d\u00f6neme bakarsak:<\/p> <ul> <li><strong>31 Temmuz 2025<\/strong>: Biogen, beklentileri alt\u00fcst ederek 3,93 $ olan EPS beklentisini 5,47 $ olarak a\u00e7\u0131klad\u0131 - hisse hemen %6 y\u00fckseldi<\/li> <li><strong>\u00d6nceki \u00e7eyrek<\/strong>: Gelir y\u0131ll\u0131k bazda %7,3 artarak 2,65 milyar $ oldu<\/li> <li><strong>Tarihsel desen<\/strong>: Pozitif s\u00fcrprizler genellikle fiyatlar\u0131 %5-10 art\u0131r\u0131rken, beklentilerin alt\u0131nda kalan sonu\u00e7lar %15-20 d\u00fc\u015f\u00fc\u015fe neden olabilir<\/li> <\/ul> <p>Ekim raporu \u00f6zellikle Leqembi'nin ticari ilerlemesi ve \u015firketin jenerik rekabetle kar\u015f\u0131 kar\u015f\u0131ya kalan eski MS ila\u00e7lar\u0131ndan azalan sat\u0131\u015flar\u0131 nas\u0131l y\u00f6netti\u011fi a\u00e7\u0131s\u0131ndan \u00f6nemli olacak.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu: Son D\u00f6nemdeki \u0130yile\u015fmeyle Dalgal\u0131 Seyir<\/h2> <p>Biogen hissesi son alt\u0131 ayda olduk\u00e7a hareketliydi:<\/p> <table> <thead> <tr><th>Ay<\/th><th>Fiyat Aral\u0131\u011f\u0131<\/th><th>\u00d6nemli Olaylar<\/th><\/tr> <\/thead> <tbody> <tr><td>Mart 2025<\/td><td>153-160 $<\/td><td>G\u00fc\u00e7l\u00fc ba\u015flang\u0131\u00e7 ancak zorluklarla kar\u015f\u0131la\u015ft\u0131<\/td><\/tr> <tr><td>Nisan 2025<\/td><td>142-150 $<\/td><td>Jenerik rekabet endi\u015feleri artt\u0131<\/td><\/tr> <tr><td>May\u0131s 2025<\/td><td>135-145 $<\/td><td>Kazan\u00e7 beklentileri a\u015f\u0131ld\u0131 ancak rehberlik temkinli<\/td><\/tr> <tr><td>Haziran 2025<\/td><td>128-138 $<\/td><td>Klinik deneme g\u00fcncellemeleri kar\u0131\u015f\u0131k<\/td><\/tr> <tr><td>Temmuz 2025<\/td><td>124-132 $<\/td><td>Y\u0131ll\u0131k dip seviyeler 124 $ civar\u0131nda<\/td><\/tr> <tr><td>A\u011fustos 2025<\/td><td>135-142 $<\/td><td>FDA onay\u0131 ile %6 art\u0131\u015f, g\u00fcncel 139,12 $<\/td><\/tr> <\/tbody> <\/table> <p><strong>Volatilitenin sebebi nedir?<\/strong> Biogen, tek bir klinik deneme sonucu veya FDA karar\u0131 ile hissenin bir g\u00fcnde %20-30 hareket edebildi\u011fi, son derece \u00f6ng\u00f6r\u00fclemez biyoteknoloji sekt\u00f6r\u00fcnde faaliyet g\u00f6steriyor. Temmuz diplerinden gelen son toparlanma, yat\u0131r\u0131mc\u0131lar\u0131n \u015firketin \u00fcr\u00fcn hatt\u0131 hakk\u0131nda daha iyimser hale geldi\u011fini g\u00f6steriyor.<\/p> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <p>Mevcut analist konsens\u00fcs\u00fc ve \u00fcr\u00fcn hatt\u0131 potansiyeline dayanarak:<\/p> <p><strong>2025 Y\u0131l Sonu<\/strong>: 160-180 $ aral\u0131\u011f\u0131 (mevcut fiyata g\u00f6re %15-30 art\u0131\u015f)<\/p> <ul> <li>Leqembi benimsenmesi ve \u00fcr\u00fcn hatt\u0131 ilerlemesi taraf\u0131ndan destekleniyor<\/li> <li><strong>Karar: AL<\/strong> - mevcut d\u00fc\u015f\u00fck de\u011ferleme f\u0131rsat sunuyor<\/li> <\/ul> <p><strong>2026 Tahmini<\/strong>: 190-220 $<\/p> <ul> <li>Leqembi'nin tam y\u0131l katk\u0131s\u0131 bekleniyor<\/li> <li>Yeni \u00fcr\u00fcn hatt\u0131 adaylar\u0131 ilerliyor<\/li> <\/ul> <p><strong>2028 Projeksiyonu<\/strong>: 250-300 $<\/p> <ul> <li>Birden fazla yeni \u00fcr\u00fcn lansman\u0131 bekleniyor<\/li> <li>N\u00f6roloji alan\u0131nda pazar liderli\u011fi g\u00fc\u00e7leniyor<\/li> <\/ul> <p><strong>2030 Vizyonu<\/strong>: 350-450 $<\/p> <ul> <li>Olas\u0131 Alzheimer hastal\u0131\u011f\u0131 i\u00e7in \u00e7\u0131\u011f\u0131r a\u00e7an tedaviler<\/li> <li>K\u00fcresel pazar varl\u0131\u011f\u0131n\u0131n geni\u015flemesi<\/li> <\/ul> <p>Geni\u015f aral\u0131k, biyoteknoloji yat\u0131r\u0131m\u0131n\u0131n ikili do\u011fas\u0131n\u0131 yans\u0131t\u0131yor - ba\u015far\u0131 b\u00fcy\u00fck \u00f6l\u00e7\u00fcde klinik deneme sonu\u00e7lar\u0131 ve d\u00fczenleyici onaylara ba\u011fl\u0131d\u0131r.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>Klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131<\/strong>: Tek bir ba\u015far\u0131s\u0131z Faz 3 denemesi hissenin %30-40 d\u00fc\u015fmesine neden olabilir<\/li> <li><strong>D\u00fczenleyici engeller<\/strong>: FDA reddi veya gecikmeleri hisse fiyat\u0131n\u0131 ciddi \u015fekilde etkileyebilir<\/li> <li><strong>Jenerik rekabet<\/strong>: Eski MS ila\u00e7lar\u0131 bask\u0131 alt\u0131nda (<a href=\"https:\/\/www.nasdaq.com\/articles\/biogen-gears-report-q2-earnings-heres-what-expect\">Tysabri biyobenzerleri 2025 4. \u00e7eyrek bekleniyor<\/a>)<\/li> <li><strong>Fiyat bask\u0131lar\u0131<\/strong>: Sa\u011fl\u0131k reformlar\u0131 ila\u00e7 fiyatlar\u0131n\u0131 etkileyebilir<\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>FDA onay ivmesi<\/strong>: Son %6 art\u0131\u015f d\u00fczenleyici ba\u015far\u0131y\u0131 g\u00f6steriyor<\/li> <li><strong>G\u00fc\u00e7l\u00fc finansallar<\/strong>: 2,27 milyar $ serbest nakit ak\u0131\u015f\u0131, %13,85 \u00f6z sermaye getirisi<\/li> <li><strong>\u00dcr\u00fcn hatt\u0131 ilerlemesi<\/strong>: Birden fazla endikasyonda Faz 3 \u00e7al\u0131\u015fmalar\u0131 ilerliyor<\/li> <li><strong>D\u00fc\u015f\u00fck de\u011ferleme<\/strong>: <a href=\"https:\/\/simplywall.st\/stocks\/us\/pharmaceuticals-biotech\/nasdaq-biib\/biogen\/news\/evaluating-biogens-prospects-after-recent-fda-approval-boost\">Simply Wall St analizine g\u00f6re<\/a> analist hedeflerine g\u00f6re %24 indirimle i\u015flem g\u00f6r\u00fcyor<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %5'inden fazlas\u0131n\u0131 y\u00fcksek volatiliteye sahip biyoteknoloji hisselerine ay\u0131rmay\u0131n<\/li> <li><strong>Dolar maliyeti ortalamas\u0131 yap\u0131n<\/strong>: Zamanlama riskini azaltmak i\u00e7in toplu de\u011fil par\u00e7a par\u00e7a sat\u0131n al\u0131n<\/li> <li><strong>Fiyat uyar\u0131lar\u0131 kurun<\/strong>: Kazan\u00e7 tarihleri civar\u0131n\u0131 takip edin (bir sonraki: 29 Ekim 2025)<\/li> <li><strong>\u00c7e\u015fitlendirin<\/strong>: BIIB'yi daha istikrarl\u0131 sa\u011fl\u0131k hisseleriyle dengeleyin<\/li> <\/ol> <p>Esprili bir bak\u0131\u015f: \"Biogen ticareti yapmak, dahi bir bilim insan\u0131yla ili\u015fki i\u00e7inde olmak gibidir - i\u015fler yolunda gitti\u011finde inan\u0131lmaz \u00f6d\u00fcllendirici, ancak deneyler tutmad\u0131\u011f\u0131nda dramatik ruh hali de\u011fi\u015fimlerine haz\u0131rl\u0131kl\u0131 olun!\"<\/p> <h2>\u2705 Biogen Inc. (BIIB) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir ticaret platformu se\u00e7in<\/td><td>NASDAQ listeli hisseleri ve makul \u00fccretleri sunmas\u0131na dikkat edin<\/td><\/tr> <tr><td>2<\/td><td>Hesab\u0131n\u0131z\u0131 a\u00e7\u0131n ve fonlay\u0131n<\/td><td>Kaybetmeyi g\u00f6ze alabilece\u011finiz bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>3<\/td><td>BIIB hakk\u0131nda kapsaml\u0131 ara\u015ft\u0131rma yap\u0131n<\/td><td>Biyoteknolojiye \u00f6zg\u00fc riskleri ve f\u0131rsatlar\u0131 anlay\u0131n<\/td><\/tr> <tr><td>4<\/td><td>Limit emri verin<\/td><td>Fazla \u00f6deme yapmamak i\u00e7in maksimum al\u0131\u015f fiyat\u0131n\u0131z\u0131 belirleyin<\/td><\/tr> <tr><td>5<\/td><td>Takip edin ve uyar\u0131lar kurun<\/td><td>Kazan\u00e7 tarihleri ve klinik deneme duyurular\u0131n\u0131 izleyin<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Neden Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Uygun?<\/h2> <p>Yat\u0131r\u0131m yolculu\u011funa ba\u015flamak isteyenler i\u00e7in Pocket Option birka\u00e7 avantaj sunar:<\/p> <ul> <li><strong>Minimum depozito: 5 $<\/strong> - Stratejileri d\u00fc\u015f\u00fck riskle test etmek i\u00e7in ideal<\/li> <li><strong>1 dakikal\u0131k KYC do\u011frulamas\u0131<\/strong> - Herhangi bir kimlik belgesini y\u00fckleyin ve hemen i\u015flem yapmaya ba\u015flay\u0131n<\/li> <li><strong>100+ para \u00e7ekme y\u00f6ntemi<\/strong> - Kripto, e-c\u00fczdanlar ve geleneksel bankac\u0131l\u0131k ile esneklik<\/li> <\/ul> <p>Platformun d\u00fc\u015f\u00fck giri\u015f engeli, ba\u015flang\u0131\u00e7ta b\u00fcy\u00fck sermaye taahh\u00fct etmeden Biogen gibi biyoteknoloji hisselerinde deneyim kazanmak isteyen yeni ba\u015flayanlar i\u00e7in idealdir.<\/p> <h2>\ud83c\udf0d 2025'te Biogen: N\u00f6robilimde Yenilik Lideri<\/h2> <p>Biogen, Alzheimer, multipl skleroz ve ALS gibi y\u0131k\u0131c\u0131 hastal\u0131klara odaklanan n\u00f6rolojik ara\u015ft\u0131rmalarda dominant bir g\u00fc\u00e7 olmaya devam ediyor. \u015eirketin <a href=\"https:\/\/www.biogen.com\/company.html\">i\u015f modeli<\/a>, \u00e7\u0131\u011f\u0131r a\u00e7an bilimi ticari uygulamalarla dengeliyor ve 1995'ten bu yana \u00fcretim kapasitesine 10 milyar dolardan fazla yat\u0131r\u0131m yapt\u0131.<\/p> <p>Son geli\u015fmeler aras\u0131nda, antisens oligon\u00fckleotid yeteneklerini geni\u015fletmek ve \u00fcretimi yapay zeka ve otomasyonla modernize etmek i\u00e7in Ara\u015ft\u0131rma \u00dc\u00e7geni Park\u0131 tesislerine <strong>2 milyar $ yat\u0131r\u0131m<\/strong> yer al\u0131yor. \u015eirket ayr\u0131ca RNA interferans tedavisi geli\u015ftirmek i\u00e7in City Therapeutics ile stratejik i\u015f birli\u011fi yapt\u0131.<\/p> <p><strong>2025 i\u00e7in \u0130lgin\u00e7 Bir Ger\u00e7ek<\/strong>: Biogen'in \u00fcretim tesisleri art\u0131k ar\u0131za olmadan \u00f6nce ekipman bak\u0131m ihtiya\u00e7lar\u0131n\u0131 tahmin etmek i\u00e7in yapay zeka kullan\u0131yor, bu da duru\u015f s\u00fcrelerini %40 azalt\u0131yor ve kritik ila\u00e7lar\u0131n hastalara s\u00fcrekli tedarikini sa\u011fl\u0131yor.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Biogen Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2>\n<p>22 A\u011fustos 2025 itibar\u0131yla, Biogen Inc. (BIIB) NASDAQ borsas\u0131nda <strong>139,12 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Takviminize not edin: <strong>29 Ekim 2025<\/strong> kesinlikle kritik &#8211; Biogen&#8217;in bir sonraki \u00e7eyrek kazan\u00e7 raporunu yay\u0131nlayaca\u011f\u0131 tarih.<\/p>\n<h3>BIIB i\u00e7in Kazan\u00e7 Tarihleri Neden \u00d6nemlidir?<\/h3>\n<p>Biyoteknoloji hisseleri klinik deneme sonu\u00e7lar\u0131 ve kazan\u00e7 raporlar\u0131na ba\u011fl\u0131 olarak y\u00fckselir veya d\u00fc\u015fer. Son d\u00f6neme bakarsak:<\/p>\n<ul>\n<li><strong>31 Temmuz 2025<\/strong>: Biogen, beklentileri alt\u00fcst ederek 3,93 $ olan EPS beklentisini 5,47 $ olarak a\u00e7\u0131klad\u0131 &#8211; hisse hemen %6 y\u00fckseldi<\/li>\n<li><strong>\u00d6nceki \u00e7eyrek<\/strong>: Gelir y\u0131ll\u0131k bazda %7,3 artarak 2,65 milyar $ oldu<\/li>\n<li><strong>Tarihsel desen<\/strong>: Pozitif s\u00fcrprizler genellikle fiyatlar\u0131 %5-10 art\u0131r\u0131rken, beklentilerin alt\u0131nda kalan sonu\u00e7lar %15-20 d\u00fc\u015f\u00fc\u015fe neden olabilir<\/li>\n<\/ul>\n<p>Ekim raporu \u00f6zellikle Leqembi&#8217;nin ticari ilerlemesi ve \u015firketin jenerik rekabetle kar\u015f\u0131 kar\u015f\u0131ya kalan eski MS ila\u00e7lar\u0131ndan azalan sat\u0131\u015flar\u0131 nas\u0131l y\u00f6netti\u011fi a\u00e7\u0131s\u0131ndan \u00f6nemli olacak.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu: Son D\u00f6nemdeki \u0130yile\u015fmeyle Dalgal\u0131 Seyir<\/h2>\n<p>Biogen hissesi son alt\u0131 ayda olduk\u00e7a hareketliydi:<\/p>\n<table>\n<thead>\n<tr>\n<th>Ay<\/th>\n<th>Fiyat Aral\u0131\u011f\u0131<\/th>\n<th>\u00d6nemli Olaylar<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Mart 2025<\/td>\n<td>153-160 $<\/td>\n<td>G\u00fc\u00e7l\u00fc ba\u015flang\u0131\u00e7 ancak zorluklarla kar\u015f\u0131la\u015ft\u0131<\/td>\n<\/tr>\n<tr>\n<td>Nisan 2025<\/td>\n<td>142-150 $<\/td>\n<td>Jenerik rekabet endi\u015feleri artt\u0131<\/td>\n<\/tr>\n<tr>\n<td>May\u0131s 2025<\/td>\n<td>135-145 $<\/td>\n<td>Kazan\u00e7 beklentileri a\u015f\u0131ld\u0131 ancak rehberlik temkinli<\/td>\n<\/tr>\n<tr>\n<td>Haziran 2025<\/td>\n<td>128-138 $<\/td>\n<td>Klinik deneme g\u00fcncellemeleri kar\u0131\u015f\u0131k<\/td>\n<\/tr>\n<tr>\n<td>Temmuz 2025<\/td>\n<td>124-132 $<\/td>\n<td>Y\u0131ll\u0131k dip seviyeler 124 $ civar\u0131nda<\/td>\n<\/tr>\n<tr>\n<td>A\u011fustos 2025<\/td>\n<td>135-142 $<\/td>\n<td>FDA onay\u0131 ile %6 art\u0131\u015f, g\u00fcncel 139,12 $<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Volatilitenin sebebi nedir?<\/strong> Biogen, tek bir klinik deneme sonucu veya FDA karar\u0131 ile hissenin bir g\u00fcnde %20-30 hareket edebildi\u011fi, son derece \u00f6ng\u00f6r\u00fclemez biyoteknoloji sekt\u00f6r\u00fcnde faaliyet g\u00f6steriyor. Temmuz diplerinden gelen son toparlanma, yat\u0131r\u0131mc\u0131lar\u0131n \u015firketin \u00fcr\u00fcn hatt\u0131 hakk\u0131nda daha iyimser hale geldi\u011fini g\u00f6steriyor.<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<p>Mevcut analist konsens\u00fcs\u00fc ve \u00fcr\u00fcn hatt\u0131 potansiyeline dayanarak:<\/p>\n<p><strong>2025 Y\u0131l Sonu<\/strong>: 160-180 $ aral\u0131\u011f\u0131 (mevcut fiyata g\u00f6re %15-30 art\u0131\u015f)<\/p>\n<ul>\n<li>Leqembi benimsenmesi ve \u00fcr\u00fcn hatt\u0131 ilerlemesi taraf\u0131ndan destekleniyor<\/li>\n<li><strong>Karar: AL<\/strong> &#8211; mevcut d\u00fc\u015f\u00fck de\u011ferleme f\u0131rsat sunuyor<\/li>\n<\/ul>\n<p><strong>2026 Tahmini<\/strong>: 190-220 $<\/p>\n<ul>\n<li>Leqembi&#8217;nin tam y\u0131l katk\u0131s\u0131 bekleniyor<\/li>\n<li>Yeni \u00fcr\u00fcn hatt\u0131 adaylar\u0131 ilerliyor<\/li>\n<\/ul>\n<p><strong>2028 Projeksiyonu<\/strong>: 250-300 $<\/p>\n<ul>\n<li>Birden fazla yeni \u00fcr\u00fcn lansman\u0131 bekleniyor<\/li>\n<li>N\u00f6roloji alan\u0131nda pazar liderli\u011fi g\u00fc\u00e7leniyor<\/li>\n<\/ul>\n<p><strong>2030 Vizyonu<\/strong>: 350-450 $<\/p>\n<ul>\n<li>Olas\u0131 Alzheimer hastal\u0131\u011f\u0131 i\u00e7in \u00e7\u0131\u011f\u0131r a\u00e7an tedaviler<\/li>\n<li>K\u00fcresel pazar varl\u0131\u011f\u0131n\u0131n geni\u015flemesi<\/li>\n<\/ul>\n<p>Geni\u015f aral\u0131k, biyoteknoloji yat\u0131r\u0131m\u0131n\u0131n ikili do\u011fas\u0131n\u0131 yans\u0131t\u0131yor &#8211; ba\u015far\u0131 b\u00fcy\u00fck \u00f6l\u00e7\u00fcde klinik deneme sonu\u00e7lar\u0131 ve d\u00fczenleyici onaylara ba\u011fl\u0131d\u0131r.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>Klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131<\/strong>: Tek bir ba\u015far\u0131s\u0131z Faz 3 denemesi hissenin %30-40 d\u00fc\u015fmesine neden olabilir<\/li>\n<li><strong>D\u00fczenleyici engeller<\/strong>: FDA reddi veya gecikmeleri hisse fiyat\u0131n\u0131 ciddi \u015fekilde etkileyebilir<\/li>\n<li><strong>Jenerik rekabet<\/strong>: Eski MS ila\u00e7lar\u0131 bask\u0131 alt\u0131nda (<a href=\"https:\/\/www.nasdaq.com\/articles\/biogen-gears-report-q2-earnings-heres-what-expect\">Tysabri biyobenzerleri 2025 4. \u00e7eyrek bekleniyor<\/a>)<\/li>\n<li><strong>Fiyat bask\u0131lar\u0131<\/strong>: Sa\u011fl\u0131k reformlar\u0131 ila\u00e7 fiyatlar\u0131n\u0131 etkileyebilir<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>FDA onay ivmesi<\/strong>: Son %6 art\u0131\u015f d\u00fczenleyici ba\u015far\u0131y\u0131 g\u00f6steriyor<\/li>\n<li><strong>G\u00fc\u00e7l\u00fc finansallar<\/strong>: 2,27 milyar $ serbest nakit ak\u0131\u015f\u0131, %13,85 \u00f6z sermaye getirisi<\/li>\n<li><strong>\u00dcr\u00fcn hatt\u0131 ilerlemesi<\/strong>: Birden fazla endikasyonda Faz 3 \u00e7al\u0131\u015fmalar\u0131 ilerliyor<\/li>\n<li><strong>D\u00fc\u015f\u00fck de\u011ferleme<\/strong>: <a href=\"https:\/\/simplywall.st\/stocks\/us\/pharmaceuticals-biotech\/nasdaq-biib\/biogen\/news\/evaluating-biogens-prospects-after-recent-fda-approval-boost\">Simply Wall St analizine g\u00f6re<\/a> analist hedeflerine g\u00f6re %24 indirimle i\u015flem g\u00f6r\u00fcyor<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %5&#8217;inden fazlas\u0131n\u0131 y\u00fcksek volatiliteye sahip biyoteknoloji hisselerine ay\u0131rmay\u0131n<\/li>\n<li><strong>Dolar maliyeti ortalamas\u0131 yap\u0131n<\/strong>: Zamanlama riskini azaltmak i\u00e7in toplu de\u011fil par\u00e7a par\u00e7a sat\u0131n al\u0131n<\/li>\n<li><strong>Fiyat uyar\u0131lar\u0131 kurun<\/strong>: Kazan\u00e7 tarihleri civar\u0131n\u0131 takip edin (bir sonraki: 29 Ekim 2025)<\/li>\n<li><strong>\u00c7e\u015fitlendirin<\/strong>: BIIB&#8217;yi daha istikrarl\u0131 sa\u011fl\u0131k hisseleriyle dengeleyin<\/li>\n<\/ol>\n<p>Esprili bir bak\u0131\u015f: &#8220;Biogen ticareti yapmak, dahi bir bilim insan\u0131yla ili\u015fki i\u00e7inde olmak gibidir &#8211; i\u015fler yolunda gitti\u011finde inan\u0131lmaz \u00f6d\u00fcllendirici, ancak deneyler tutmad\u0131\u011f\u0131nda dramatik ruh hali de\u011fi\u015fimlerine haz\u0131rl\u0131kl\u0131 olun!&#8221;<\/p>\n<h2>\u2705 Biogen Inc. (BIIB) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir ticaret platformu se\u00e7in<\/td>\n<td>NASDAQ listeli hisseleri ve makul \u00fccretleri sunmas\u0131na dikkat edin<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesab\u0131n\u0131z\u0131 a\u00e7\u0131n ve fonlay\u0131n<\/td>\n<td>Kaybetmeyi g\u00f6ze alabilece\u011finiz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>BIIB hakk\u0131nda kapsaml\u0131 ara\u015ft\u0131rma yap\u0131n<\/td>\n<td>Biyoteknolojiye \u00f6zg\u00fc riskleri ve f\u0131rsatlar\u0131 anlay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Limit emri verin<\/td>\n<td>Fazla \u00f6deme yapmamak i\u00e7in maksimum al\u0131\u015f fiyat\u0131n\u0131z\u0131 belirleyin<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Takip edin ve uyar\u0131lar kurun<\/td>\n<td>Kazan\u00e7 tarihleri ve klinik deneme duyurular\u0131n\u0131 izleyin<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Neden Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Uygun?<\/h2>\n<p>Yat\u0131r\u0131m yolculu\u011funa ba\u015flamak isteyenler i\u00e7in Pocket Option birka\u00e7 avantaj sunar:<\/p>\n<ul>\n<li><strong>Minimum depozito: 5 $<\/strong> &#8211; Stratejileri d\u00fc\u015f\u00fck riskle test etmek i\u00e7in ideal<\/li>\n<li><strong>1 dakikal\u0131k KYC do\u011frulamas\u0131<\/strong> &#8211; Herhangi bir kimlik belgesini y\u00fckleyin ve hemen i\u015flem yapmaya ba\u015flay\u0131n<\/li>\n<li><strong>100+ para \u00e7ekme y\u00f6ntemi<\/strong> &#8211; Kripto, e-c\u00fczdanlar ve geleneksel bankac\u0131l\u0131k ile esneklik<\/li>\n<\/ul>\n<p>Platformun d\u00fc\u015f\u00fck giri\u015f engeli, ba\u015flang\u0131\u00e7ta b\u00fcy\u00fck sermaye taahh\u00fct etmeden Biogen gibi biyoteknoloji hisselerinde deneyim kazanmak isteyen yeni ba\u015flayanlar i\u00e7in idealdir.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te Biogen: N\u00f6robilimde Yenilik Lideri<\/h2>\n<p>Biogen, Alzheimer, multipl skleroz ve ALS gibi y\u0131k\u0131c\u0131 hastal\u0131klara odaklanan n\u00f6rolojik ara\u015ft\u0131rmalarda dominant bir g\u00fc\u00e7 olmaya devam ediyor. \u015eirketin <a href=\"https:\/\/www.biogen.com\/company.html\">i\u015f modeli<\/a>, \u00e7\u0131\u011f\u0131r a\u00e7an bilimi ticari uygulamalarla dengeliyor ve 1995&#8217;ten bu yana \u00fcretim kapasitesine 10 milyar dolardan fazla yat\u0131r\u0131m yapt\u0131.<\/p>\n<p>Son geli\u015fmeler aras\u0131nda, antisens oligon\u00fckleotid yeteneklerini geni\u015fletmek ve \u00fcretimi yapay zeka ve otomasyonla modernize etmek i\u00e7in Ara\u015ft\u0131rma \u00dc\u00e7geni Park\u0131 tesislerine <strong>2 milyar $ yat\u0131r\u0131m<\/strong> yer al\u0131yor. \u015eirket ayr\u0131ca RNA interferans tedavisi geli\u015ftirmek i\u00e7in City Therapeutics ile stratejik i\u015f birli\u011fi yapt\u0131.<\/p>\n<p><strong>2025 i\u00e7in \u0130lgin\u00e7 Bir Ger\u00e7ek<\/strong>: Biogen&#8217;in \u00fcretim tesisleri art\u0131k ar\u0131za olmadan \u00f6nce ekipman bak\u0131m ihtiya\u00e7lar\u0131n\u0131 tahmin etmek i\u00e7in yapay zeka kullan\u0131yor, bu da duru\u015f s\u00fcrelerini %40 azalt\u0131yor ve kritik ila\u00e7lar\u0131n hastalara s\u00fcrekli tedarikini sa\u011fl\u0131yor.<\/p>\n"},"faq":[{"question":"Biogen hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Biogen hisseleri sat\u0131n almak i\u00e7in \u00f6ncelikle NASDAQ borsas\u0131nda i\u015flem yapan bir ticaret platformu se\u00e7meli, hesab\u0131n\u0131z\u0131 a\u00e7\u0131p fonlamal\u0131, BIIB hakk\u0131nda ara\u015ft\u0131rma yapmal\u0131, limit emri vermeli ve kazan\u00e7 tarihlerini takip etmelisiniz."},{"question":"Biogen hisselerinin fiyat\u0131 ne kadar?","answer":"22 A\u011fustos 2025 itibar\u0131yla Biogen hisseleri NASDAQ'da 139,12 $ seviyesinde i\u015flem g\u00f6rmektedir."},{"question":"Biogen hisseleri i\u00e7in 2025 sonras\u0131 fiyat tahmini nedir?","answer":"Analistlerin tahminlerine g\u00f6re 2025 y\u0131l sonu fiyat\u0131 160-180 $ aral\u0131\u011f\u0131nda, 2026'da 190-220 $, 2028'de 250-300 $ ve 2030'da 350-450 $ aral\u0131\u011f\u0131nda olabilir."},{"question":"Biogen hisseleri yat\u0131r\u0131m\u0131nda hangi riskler vard\u0131r?","answer":"Ba\u015fl\u0131ca riskler aras\u0131nda klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131, d\u00fczenleyici engeller, jenerik rekabet ve fiyat bask\u0131lar\u0131 bulunmaktad\u0131r."},{"question":"Yeni ba\u015flayanlar Biogen hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"Yeni ba\u015flayanlar k\u00fc\u00e7\u00fck ba\u015flay\u0131p portf\u00f6ylerinin %5'inden fazlas\u0131n\u0131 ay\u0131rmamal\u0131, dolar maliyeti ortalamas\u0131 yapmal\u0131, fiyat uyar\u0131lar\u0131 kurmal\u0131 ve portf\u00f6ylerini \u00e7e\u015fitlendirmelidir."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Biogen hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Biogen hisseleri sat\u0131n almak i\u00e7in \u00f6ncelikle NASDAQ borsas\u0131nda i\u015flem yapan bir ticaret platformu se\u00e7meli, hesab\u0131n\u0131z\u0131 a\u00e7\u0131p fonlamal\u0131, BIIB hakk\u0131nda ara\u015ft\u0131rma yapmal\u0131, limit emri vermeli ve kazan\u00e7 tarihlerini takip etmelisiniz."},{"question":"Biogen hisselerinin fiyat\u0131 ne kadar?","answer":"22 A\u011fustos 2025 itibar\u0131yla Biogen hisseleri NASDAQ'da 139,12 $ seviyesinde i\u015flem g\u00f6rmektedir."},{"question":"Biogen hisseleri i\u00e7in 2025 sonras\u0131 fiyat tahmini nedir?","answer":"Analistlerin tahminlerine g\u00f6re 2025 y\u0131l sonu fiyat\u0131 160-180 $ aral\u0131\u011f\u0131nda, 2026'da 190-220 $, 2028'de 250-300 $ ve 2030'da 350-450 $ aral\u0131\u011f\u0131nda olabilir."},{"question":"Biogen hisseleri yat\u0131r\u0131m\u0131nda hangi riskler vard\u0131r?","answer":"Ba\u015fl\u0131ca riskler aras\u0131nda klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131, d\u00fczenleyici engeller, jenerik rekabet ve fiyat bask\u0131lar\u0131 bulunmaktad\u0131r."},{"question":"Yeni ba\u015flayanlar Biogen hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"Yeni ba\u015flayanlar k\u00fc\u00e7\u00fck ba\u015flay\u0131p portf\u00f6ylerinin %5'inden fazlas\u0131n\u0131 ay\u0131rmamal\u0131, dolar maliyeti ortalamas\u0131 yapmal\u0131, fiyat uyar\u0131lar\u0131 kurmal\u0131 ve portf\u00f6ylerini \u00e7e\u015fitlendirmelidir."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Biogen Inc. (BIIB) Hisseleri Nas\u0131l Al\u0131n\u0131r - Biogen Inc. (BIIB) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biogen-2\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biogen Inc. (BIIB) Hisseleri Nas\u0131l Al\u0131n\u0131r - Biogen Inc. (BIIB) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biogen-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-22T11:53:14+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biogen-2\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biogen-2\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Biogen Inc. (BIIB) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Biogen Inc. (BIIB) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-22T11:53:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biogen-2\/\"},\"wordCount\":19,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biogen-2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biogen-2\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biogen-2\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biogen-2\/\",\"name\":\"Biogen Inc. (BIIB) Hisseleri Nas\u0131l Al\u0131n\u0131r - Biogen Inc. (BIIB) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biogen-2\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biogen-2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"datePublished\":\"2025-08-22T11:53:14+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biogen-2\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biogen-2\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biogen-2\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biogen-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Biogen Inc. (BIIB) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Biogen Inc. (BIIB) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Biogen Inc. (BIIB) Hisseleri Nas\u0131l Al\u0131n\u0131r - Biogen Inc. (BIIB) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biogen-2\/","og_locale":"tr_TR","og_type":"article","og_title":"Biogen Inc. (BIIB) Hisseleri Nas\u0131l Al\u0131n\u0131r - Biogen Inc. (BIIB) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biogen-2\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-22T11:53:14+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biogen-2\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biogen-2\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Biogen Inc. (BIIB) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Biogen Inc. (BIIB) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-22T11:53:14+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biogen-2\/"},"wordCount":19,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biogen-2\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biogen-2\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biogen-2\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biogen-2\/","name":"Biogen Inc. (BIIB) Hisseleri Nas\u0131l Al\u0131n\u0131r - Biogen Inc. (BIIB) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biogen-2\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biogen-2\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","datePublished":"2025-08-22T11:53:14+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biogen-2\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biogen-2\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biogen-2\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biogen-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Biogen Inc. (BIIB) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Biogen Inc. (BIIB) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":343429,"slug":"how-to-buy-biogen-2","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Biogen Inc. (BIIB) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Biogen Inc. (BIIB)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-biogen-2\/"},"pt_AA":{"locale":"pt_AA","id":343425,"slug":"how-to-buy-biogen-2","post_title":"Como comprar a\u00e7\u00f5es da Biogen Inc. (BIIB) - Investimento em a\u00e7\u00f5es da Biogen Inc. (BIIB)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-biogen-2\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/343428","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=343428"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/343428\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334081"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=343428"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=343428"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=343428"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}